about
The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristicsNontraditional Lipid Variables Predict Recurrent Brain Ischemia in Embolic Stroke of Undetermined Source.Cortical microstructural changes along the Alzheimer's disease continuum.Advances on Automatic Speech Analysis for Early Detection of Alzheimer Disease: A Non-linear Multi-task Approach.Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease.Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>A Progranulin Mutation CarriersThe First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis PatientsHLA-DR2 and White Matter Lesion Distribution in MSIncreased CAIDE dementia risk, cognition, CSF biomarkers, and vascular burden in healthy adultsChanges in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal FluidReversible delayed post-hypoxic leukoencephalopathyIsopropanol extraction for cerebrospinal fluid lipidomic profiling analysisPrimary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortCerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumA metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalizationValidation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery CohortLongitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD studyDiscovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay[Rhomboencephalitis and endocarditis caused by Listeria monocytogenes: an unreported association]
P50
Q33778423-AE21002A-5CFC-4210-84FA-928F6BE2F555Q38835590-858B09F1-62C3-4E74-A260-F9E74AE9D701Q47231424-FB036902-C441-4918-B255-F8CD2594BE58Q47324118-13B55F3F-95F7-4C41-AD83-AAC219CCD534Q48201163-D90F311C-4FDA-405C-8698-929F3E16496FQ58104434-956FB734-ACE0-41B3-B866-44752A2E3E62Q58766024-A3A86938-AE90-409E-A1EA-04F56B10DFA9Q59854921-861E0993-2BF8-4BEB-876E-71B0F4EFE0E4Q61439687-4C1D10BA-9EB2-4D9A-AD85-10D69E4B61AAQ64450771-3206E7B6-0E8B-4E10-B165-70FFA5812A07Q87093627-15376F2E-D971-40C3-B72E-867B262A0140Q90965178-5181B4E4-7487-4B78-9034-E935DF1D21ACQ91947146-86FE47E8-E377-47AB-A734-867B74DCF6F9Q92252802-479CE234-954A-4513-A1E3-1304C6AC2AE3Q92345820-A1283FDE-C07F-44B0-A598-9A5866DD3CA9Q92626330-1A72E21E-1937-42CE-93A5-EE2D9B99396AQ92963166-147E97CF-52F6-4068-9BD2-172A5C08722CQ92985206-4CF6FC05-8432-480E-B34E-213B4090EAB6Q93178292-D08F0236-2E20-4707-B2D4-2FF5F57A79B7Q95428656-839A4337-2DC1-43D2-9970-942EB83E8CEC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mikel Tainta
@ast
Mikel Tainta
@en
Mikel Tainta
@es
Mikel Tainta
@nl
Mikel Tainta
@sl
type
label
Mikel Tainta
@ast
Mikel Tainta
@en
Mikel Tainta
@es
Mikel Tainta
@nl
Mikel Tainta
@sl
prefLabel
Mikel Tainta
@ast
Mikel Tainta
@en
Mikel Tainta
@es
Mikel Tainta
@nl
Mikel Tainta
@sl
P106
P21
P31
P496
0000-0003-0624-1211